Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John M Davis

Showing results (341-350 of 437) with videos related to

Pageof 44
Sort By:
BMJ (Clinical Research Ed.)|April 14, 2016
Re-evaluation of the traditional diet-heart hypothesis: analysis of recovered data from Minnesota Coronary Experiment (1968-73)Christopher E Ramsden, Daisy Zamora, Sharon Majchrzak-Hong, et al.
Frontiers in Immunology|October 21, 2024
Clinical phenotype, <i>NOD2</i> genotypes, and treatment observations in Yao syndrome: a retrospective case seriesKatrina A Williamson, Matthew J Samec, Jenny A Patel, et al.
The Journal of Rheumatology|May 1, 2026
Deep Learning-Based Comparison of Knee Minimum Joint Space Width in Patients with Rheumatoid Arthritis and Osteoarthritis Before Total Knee ArthroplastyMiguel M Girod, Monty Khela, Sami Saniei, et al.
Plant Biotechnology Journal|June 19, 2007
Efficiency of gene silencing in Arabidopsis: direct inverted repeats vs. transitive RNAi vectorsSergei A Filichkin, Stephen P DiFazio, Amy M Brunner, et al.
Cardiovascular Research|March 30, 2002
Thrombostatin, a bradykinin metabolite, reduces platelet activation in a model of arterial wall injuryAlejandro R Prieto, Hongbao Ma, Ruiping Huang, et al.
Schizophrenia Bulletin|February 21, 2025
Is it Possible To Identify Patients After Their First Hospitalization for a Psychotic Disorder Who Do Not Use Anti-Psychotics and are Not Later Rehospitalized?Amir Krivoy, Jari Tiihonen, Johnatan Nissan, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|January 14, 2023
Metabolic side effects in persons with schizophrenia during mid- to long-term treatment with antipsychotics: a network meta-analysis of randomized controlled trialsAngelika Burschinski, Johannes Schneider-Thoma, Virginia Chiocchia, et al.
The American Journal of Psychiatry|June 20, 2012
Metformin for treatment of antipsychotic-induced amenorrhea and weight gain in women with first-episode schizophrenia: a double-blind, randomized, placebo-controlled studyRen-Rong Wu, Hua Jin, Keming Gao, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 29, 2021
The Epidemiology of Psoriatic Arthritis Over Five Decades: A Population-Based StudyParas Karmacharya, Cynthia S Crowson, Delamo Bekele, et al.
The Journal of Clinical Psychiatry|May 26, 2017
Raloxifene Plus Antipsychotics Versus Placebo Plus Antipsychotics in Severely Ill Decompensated Postmenopausal Women With Schizophrenia or Schizoaffective Disorder: A Randomized Controlled TrialMark Weiser, Linda Levi, Shimon Burshtein, et al.
Pageof 44

Showing results (341-350 of 437) with videos related to

Sort By:
Pageof 44
BMJ (Clinical Research Ed.)|April 14, 2016
Re-evaluation of the traditional diet-heart hypothesis: analysis of recovered data from Minnesota Coronary Experiment (1968-73)Christopher E Ramsden, Daisy Zamora, Sharon Majchrzak-Hong, et al.
Frontiers in Immunology|October 21, 2024
Clinical phenotype, <i>NOD2</i> genotypes, and treatment observations in Yao syndrome: a retrospective case seriesKatrina A Williamson, Matthew J Samec, Jenny A Patel, et al.
The Journal of Rheumatology|May 1, 2026
Deep Learning-Based Comparison of Knee Minimum Joint Space Width in Patients with Rheumatoid Arthritis and Osteoarthritis Before Total Knee ArthroplastyMiguel M Girod, Monty Khela, Sami Saniei, et al.
Plant Biotechnology Journal|June 19, 2007
Efficiency of gene silencing in Arabidopsis: direct inverted repeats vs. transitive RNAi vectorsSergei A Filichkin, Stephen P DiFazio, Amy M Brunner, et al.
Cardiovascular Research|March 30, 2002
Thrombostatin, a bradykinin metabolite, reduces platelet activation in a model of arterial wall injuryAlejandro R Prieto, Hongbao Ma, Ruiping Huang, et al.
Schizophrenia Bulletin|February 21, 2025
Is it Possible To Identify Patients After Their First Hospitalization for a Psychotic Disorder Who Do Not Use Anti-Psychotics and are Not Later Rehospitalized?Amir Krivoy, Jari Tiihonen, Johnatan Nissan, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|January 14, 2023
Metabolic side effects in persons with schizophrenia during mid- to long-term treatment with antipsychotics: a network meta-analysis of randomized controlled trialsAngelika Burschinski, Johannes Schneider-Thoma, Virginia Chiocchia, et al.
The American Journal of Psychiatry|June 20, 2012
Metformin for treatment of antipsychotic-induced amenorrhea and weight gain in women with first-episode schizophrenia: a double-blind, randomized, placebo-controlled studyRen-Rong Wu, Hua Jin, Keming Gao, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 29, 2021
The Epidemiology of Psoriatic Arthritis Over Five Decades: A Population-Based StudyParas Karmacharya, Cynthia S Crowson, Delamo Bekele, et al.
The Journal of Clinical Psychiatry|May 26, 2017
Raloxifene Plus Antipsychotics Versus Placebo Plus Antipsychotics in Severely Ill Decompensated Postmenopausal Women With Schizophrenia or Schizoaffective Disorder: A Randomized Controlled TrialMark Weiser, Linda Levi, Shimon Burshtein, et al.
Pageof 44